ArticleDiscover oncology2026

Multi-dimensional analysis reveals the potential of PDK4 as a tumor biomarker and target for immunotherapy.

Yaxing Deng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.